REFERENCES
- Satel SL, Southwick SM, Gawin FH. Clinical features of cocaine-induced paranoia. Am J Psychiatry. 1991; 1248: 495–498
- Brady KT, Lydiard B, Malcolm R, Ballinger JC. Cocaine-induced psychosis. J Clin Psychiatry. 1991; 52: 509–512. [PUBMED], [INFOTRIEVE]
- Bartlett E, Hallin A, Chapman B, Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology. 1997; 16: 77–82. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993; 18: 247–291. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res. 1974; 11: 137–23. [CROSSREF]
- Sekine Y, Iyo M, Ouchi Y, et al, Methamphetamine-related symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiat M. 2001; 158: 1206–1214. [CROSSREF]
- Ciccocioppo R, Sanna PP, Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence reversal by D (1) antagonists. Proc Natl Acad Sci USA. 2001; 98: 1976–1981. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, Ben-Shahar O. Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharmacology. 2001; 25: 361–372. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Childress AR, Mozley D, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999; 156: 11–18. [PUBMED], [INFOTRIEVE]
- Grant S, London ED, Newlin DB, et al, Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA. 1996; 93: 12040–12045. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Maas LC, Scott EL, Kaufman MJ, et al, Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 1998; 155: 124–126. [PUBMED], [INFOTRIEVE]
- Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW. Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharm. 1999; 143: 102–110. [CROSSREF]
- Haney M, Ward AS, Foltin RW, Fischman MW. Effect of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration in humans. Psychopharm. 2001; 155: 330–337. [CROSSREF]
- Reid MS, Prichep LS, Ciplet D, O'Leary S, Tom ML, Howard B, Rotrosen J, John R. Quantitative electroencephalographic studies of cue-induced cocaine craving. Clin. Electroencephalography. 2003; 34: 110–123
- Mc Lellan AT, Kushner H, Metzger D, et al, The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9: 199–213. [CROSSREF]
- Mezinskis J, Dyrenforth S, Goldsmith RJ, Somoza E. Craving and withdrawal symptoms for various drugs of abuse. Psychiatric Annals. 1998; 28: 577–583
- Berger SP, Hall SM, Mickalian JD, et al, Haloperidol antagonism of cue-elicited cocaine craving. Lancet. 1996; 347: 504–508. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Halikas JA, Kuhn KL, Crosby R, Carlson G, Crea F. The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr. Psychiatry. 1991; 32: 22–27. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Satel SL, Price LH, Palumbo JM, et al, Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry. 1991; 148: 1712–1716. [PUBMED], [INFOTRIEVE]